Integra Lifesciences Holdings (IART) Free Cash Flow (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Free Cash Flow of $10.5 million for Q2 2026, up 308.03% sequentially from -$5.0 million in Q1 2026, and up 193.48% YoY from $3.6 million in Q2 2025.
Integra Lifesciences Holdings (IART) Free Cash Flow (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Free Cash Flow for 18 years, with the latest figure at $10.5 million in Q2 2026.
- Quarterly Free Cash Flow rose 193.48% year-over-year to $10.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $25.8 million (up 168.94% YoY) and the FY2025 annual result came in at -$31.1 million, down 224.39% from the prior year.
- Free Cash Flow improved to $10.5 million in Q2 2026 per IART's latest filing, from -$5.0 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $70.9 million in Q4 2022 and troughed at -$40.2 million in Q1 2025.
- A 5-year average of $16.4 million and a median of $12.6 million in 2023 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 459.59% in 2025, down 13906.53% in 2025.
- Over 5 years, Free Cash Flow stood at $70.9 million in 2022, then sank by 51.73% to $34.2 million in 2023, then tumbled by 38.21% to $21.1 million in 2024, then sank by 125.53% to -$5.4 million in 2025, then jumped by 294.42% to $10.5 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $10.5 million, -$5.0 million, and -$5.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 10.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.50 Mn |
| Jun 30, 2026 | 10.50 Mn |
| Mar 31, 2026 | -5.05 Mn |
| Mar 31, 2026 | -5.05 Mn |
| Dec 31, 2025 | -5.40 Mn |
| Dec 31, 2025 | -5.40 Mn |
| Sep 30, 2025 | 25.75 Mn |
| Sep 30, 2025 | 25.75 Mn |
| Jun 30, 2025 | -11.23 Mn |
| Jun 30, 2025 | -11.23 Mn |
| Mar 31, 2025 | -40.18 Mn |
| Mar 31, 2025 | -40.18 Mn |
| Dec 31, 2024 | 21.14 Mn |
| Dec 31, 2024 | 21.14 Mn |
| Sep 30, 2024 | -7.16 Mn |
| Sep 30, 2024 | -7.16 Mn |
| Jun 30, 2024 | 10.69 Mn |
| Jun 30, 2024 | 10.69 Mn |
| Mar 31, 2024 | 291,000.00 |
| Mar 31, 2024 | 291,000.00 |